Background To examine prospectively the association between self-reported symptoms of phobic anxiety and subsequent risk of coronary heart disease, a 2-year follow-up study was conducted of a cohort of 33 999 US male health professionals, aged 42 to 77 years in 1988, who were free of diagnosed cardiovascular disease at baseline. Levels of phobic anxiety were assessed using the Crown-Crisp index, a short, diagnostic self-rating scale used for common phobias. Main outcomes were incidents of coronary heart disease consisting of nonfatal myocardial infarction (MI) and fatal coronary heart disease (CHD).
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Methods and Resuls One hundred sixty-eight incident cases of CHD occurred during 2 years of follow-up (128 cases of nonfatal MI and 40 cases of fatal CHD). The age-adjusted relative risk of fatal CHD among men with highest levels of phobic anxiety (scoring 4 or higher on the Crown-Crisp index) was 3.01 (95% confidence interval, 1 .31 to 6 .90) compared with men with the lowest levels of anxiety (scoring 0 or 1 on the phobia index). Risk of fatal CHD increased with levels of phobic anxiety (P trend=.002). When fatal CHD was further categorized into sudden and nonsudden coronary death, the excess risk was confined to sudden death (relative risk among men scoring 3 
Assessment of Phobia and Other Exposures
All participants in the study were asked to complete the phobic anxiety scale of the Crown-Crisp experiential index as part of the 1988 mailed questionnaire. These questions were included specifically to address the hypothesis that phobic anxiety is a risk factor for CHD. The index measures personality traits and symptoms of phobic anxiety and has been validated in psychiatric outpatients." It is a standardized, self-rating inventory of eight questions with two to three levels of possible responses to each question, allowing scores ranging from 0 to 16 (with higher scores given to higher levels of phobic anxiety)." After a previous study that used the Crown-Crisp index,' we categorized respondents into groups based on their item scores: 0 or 1 (reference category), 2, 3, and 4 or higher (highest levels of phobic anxiety).
In addition to the items on phobia, we obtained information from the 2-yearly questionnaires on the participants' medical history, current smoking habits, weight, height, levels of physical activity, alcohol intake, and parental history of MI, including the age of each parent at the first event. 
Results
The scores on the phobic anxiety index ranged from 0 to 10 (out of a possible maximum score of 16) in this population. We categorized men into the following groups: 0 or 1 (reference category, corresponding to the lowest levels of self-reported symptoms: 68.6% of the population), 2 (14.3%), 3 (10.3%), or 4 or more (6.8%). As noted in previous studies,14 the age-standardized prevalence of smoking increased with levels of phobic anxiety, although the overall prevalence of current smoking in this population was below 10% ( to an excess risk of sudden death ( 
Discussion
Our prospective data show a strong association between phobic anxiety and fatal CHD, in particular, sudden death. The association could not be explained by confounding by smoking habit, alcohol intake, and a broad range of other cardiovascular risk factors. The specificity of the association with fatal CHD as well as the dose-response gradient are both consistent with the Northwick Park Heart study, which also used the Crown-Crisp index as the measure of phobic anxiety.1
In that prospective study, based on a population of 1457 healthy white men aged 40 to 64 years, the authors found a multivariate RR of fatal CHD of 2.54 (95% CI, 1.08 to 5.98) among men who scored 3 or 4 on the index, and an RR of 3.77 (95% CI, 1.64 to 8.64) among men who scored 5 or higher. As in the present study, no elevated risks were observed for nonfatal ischemic heart disease. On the other hand, the Northwick Park Heart tAdjusted for age (5-year age categories), deciles of body mass index, smoking habit (never, past, and current in categories of 1 to 14, 15 to 24, and 25 or more cigarettes per day), history of hypertension, diabetes mellitus, hypercholesterolemia, parental history of myocardial infarction before age 60 years, daily alcohol intake (0, 0.01-4.9, 5.0-14.9, 15.0-24.9, 25.049.9, or >50 or more g/d), and tertUes of physical activity. study did not distinguish between sudden coronary death and nonsudden fatal CHD. Our study suggests that the risk of phobic anxiety is specific to sudden coronary death.
A recent general practice-based, case-control study of fatal MI in British women aged 16 to 39 years found excess risks for use of benzodiazepines (OR, 3.7; 95% CI, 2.1 to 6.4), tricyclic antidepressants (OR, 2.7; 95% CI, 1.5 to 4.9), and barbiturates (OR, 12.0; 95% CI, 1.4 to 98).10 Although the authors acknowledged that use of psychotropic drugs may be a marker for panic disorder or phobic anxiety, no data on psychiatric history were provided. Both benzodiazepines and tricyclic antidepressants are effective treatments for panic disorder.15 While tricyclics can have effects on cardiac electrophysiology (especially prolongation of the QT interval, which may predispose to arrhythmia), benzodiazepines are free of adverse cardiac effects. The finding of similarly elevated risks of fatal MI for the two drugs suggests a common link with a condition leading to their prescription rather than a drug-associated adverse effect. Such an interpretation is supported by the finding in the present study of an elevated risk of fatal CHD within the subgroup of men receiving no medication.
Several other studies have also suggested an association between CHD and phobic anxiety or panic disorder.2-4 Weissman et a14 reported a cross-sectional study among 5034 residents in New Haven, Conn, who were surveyed regarding lifetime diagnosis of panic disorder and self-reported prevalence of heart attack and stroke. An association was found between panic disorder and heart attack (OR adjusted for age, sex and socioeconomic status, 4.5; 95% CI, 1.7 to 12.3), as well as stroke (OR, 11.9; 95% CI, 4.2 to 33.8), although the selfreported diagnoses of cardiovascular events were not confirmed by independent medical review.
A 35-year follow-up study of male inpatients with panic disorder reported a standardized cardiovascular mortality ratio of 2.0 (P<.01) relative to age-, period-, and sex-matched general population.2 The diagnostic specificity of the association between panic disorder and CHD was apparent from the absence of excess risk among similarly followed cohorts with primary depression3 or obsessive-compulsive disorder. 16 A potential limitation of the present study is that our cohort consists of male health care professionals, so our results may not be generalizable to the general population. About 80% of patients affected with phobic anxiety are women.56 Our group is currently investigating this association in two cohorts of over 200 000 women. Our study did not seek to obtain information on the clinical diagnosis of panic disorder. On the other hand, the instrument we used has been validated in psychiatric outpatients and used extensively in other studies.1'1147- '9 No information is available on the stability of CrownCrisp index scores over time. However, the symptoms of phobic anxiety are generally known to begin in early adulthood, and the natural course of phobic disorders tends to be chronic in nature. 20 In the present study, higher levels of phobic anxiety were associated with higher self-reported prevalence of hypertension, high cholesterol, and diabetes ( In summary, we have shown that apparently well men at higher risk of sudden death can be identified by a series of simple, self-administered questions. The specificity of the association between phobic anxiety and fatal CHD, the consistency and biological plausibility of the experimental, clinical, and epidemiological evidence, as well as the strength and dose-response gradient of the association together suggest a causal relation of phobia to fatal CHD, particularly sudden death.
